AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea · Delayed Price · Currency is KRW 62,500
-3,700 (-5.59%)
At close: Mar 19, 2026
AprilBio Market Cap
AprilBio has a market cap or net worth of 1.51 trillion as of March 20, 2026. Its market cap has increased by 268.72% in one year.
Market Cap
1.51T
Enterprise Value
1.41T
Revenue
2.17B
Ranking
n/a
PE Ratio
n/a
Stock Price
62,500.00
Market Cap Chart
Since July 28, 2022, AprilBio's market cap has increased from 229.75B to 1.51T, an increase of 555.33%. That is a compound annual growth rate of 67.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 1.51T | 18.17% |
| Dec 30, 2025 | 1.27T | 250.56% |
| Dec 30, 2024 | 363.46B | -0.02% |
| Dec 28, 2023 | 363.53B | 96.13% |
| Dec 29, 2022 | 185.35B | -19.33% |
| Jul 28, 2022 | 229.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aimed Bio | 3.91T |
| Rznomics | 2.73T |
| ROKIT Healthcare | 2.01T |
| Qurient | 1.82T |
| JS Link | 1.32T |
| Inventage Lab | 1.05T |
| HansBiomed | 777.24B |
| IntoCell | 741.59B |